|
Please
mark and submit your answers on the Post-Test
/ Evaluation Form . After reviewing the webposting carefully,
indicate your answers to the quiz questions on the answer sheet. There
is only one correct answer for each question. Circle the letter on the
answer sheet representing the best answer to each question.
CME Questions
1. Which of the following is NOT considered first-line defense therapy for bone disease in Chronic Renal Insufficiency patients?
a) Calcium supplementation
b) Alendronate
(Fosamax)
c) Restrict
phosphorous to 800-1,000 mg/day
d) Phosphate
binders
2. Which of the following is considered the best place to measure bone density:
a) Ankle
b) Knee
c) Hip
d) Elbow
3. If GFR is 50mL-60mL/min and PTH is normal, what treatment is recommended?
a) Use calcium therapy
and vitamin D
b) Add phosphate
binder
c) Decrease
of discontinue vitamin D therapy
d) Mild dietary
phosphorous restriction
e) All of the
above
f) A and D
4. The incidence of ESRD is highest in which nation?
a) Japan
b) United States
c) Israel
d) Russia
5. Treating anemia in CKD patients is associated with and may lead to all of the following EXCEPT:
a) Decreased hospitalization
b) Regression
of LVH
c) Improved
cognitive function
d) Increased
blood loss
6. Which of the following is NOT an advantage of administering IV ferric gluconate over iron dextran?
a) There is a lower
rate of drug intolerance
b) There is
a lower rate of life-threatening reactions
c) It is not
a true allergan (does not stimulate mast cell degranulation)
d) It can be
given as a total dose infusion
7. Studies have shown that ESRD patients on EPO had significantly more rapid and higher hemoglobin levels achieved when:
a) They also received
oral iron
b) They also
received IV iron
c) They received
folate at supplementation
d) No iron supplementation
was given